Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 152798, 9 pages
http://dx.doi.org/10.1155/2013/152798
Research Article

Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine

Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China

Received 4 October 2013; Accepted 19 November 2013

Academic Editor: Wenxia Zhou

Copyright © 2013 Jian Yu Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kabuto and T. T. Yamanushi, “Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced parkinson's disease mouse model,” Neurochemical Research, vol. 36, no. 12, pp. 2244–2249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Blandini, “Neural and immune mechanisms in the pathogenesis of Parkinson's disease,” Journal Neuroimmune Pharmacology, vol. 8, no. 1, pp. 189–201, 2013. View at Google Scholar
  3. E. C. Hirsch, P. Jenner, and S. Przedborski, “Pathogenesis of Parkinson's disease,” Movement Disorders, vol. 28, no. 1, pp. 24–30, 2013. View at Google Scholar
  4. H. Kabuto, T. T. Yamanushi, N. Janjua et al., “Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model,” Journal of Oleo Science, vol. 62, no. 1, pp. 21–28, 2013. View at Google Scholar
  5. S. Koppula, H. Kumar, S. V. More et al., “Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease,” Molecules, vol. 17, no. 10, pp. 11391–11420, 2012. View at Google Scholar
  6. C. Venkateshappa, G. Harish, R. B. Mythri, A. Mahadevan, M. M. Srinivas Bharath, and S. K. Shankar, “Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease,” Neurochemical Research, vol. 37, no. 2, pp. 358–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Nikam, P. Nikam, S. K. Ahaley, and A. V. Sontakke, “Oxidative stress in Parkinson's disease,” Indian Journal of Clinical Biochemistry, vol. 24, no. 1, pp. 98–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Huang, W. Liu, Q. Li, and F. W. Chun, “Endogenous released ascorbic acid suppresses ethanol-induced hydroxyl radical production in rat striatum,” Brain Research, vol. 944, no. 1-2, pp. 90–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Singh, V. Pillay, and Y. E. Choonara, “Advances in the treatment of Parkinson's disease,” Progress in Neurobiology, vol. 81, no. 1, pp. 29–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Van Kampen, H. Robertson, T. Hagg, and R. Drobitch, “Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease,” Experimental Neurology, vol. 184, no. 1, pp. 521–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. A. Youdim and J. A. Joseph, “A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects,” Free Radical Biology and Medicine, vol. 30, no. 6, pp. 583–594, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-C. Chen, Y.-G. Zhu, L.-A. Zhu et al., “Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress,” European Journal of Pharmacology, vol. 473, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Wang, M. Y. Liu, F. Wang et al., “Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease,” Pharmacology Biochemistry and Behavior, vol. 106, pp. 57–67, 2013. View at Google Scholar
  14. Z. Li, C. F. Wu, G. Pei, Y. Y. Guo, and X. Li, “Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice,” Pharmacology Biochemistry and Behavior, vol. 66, no. 3, pp. 595–601, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Li, N.-J. Xu, C.-F. Wu et al., “Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-μ cells,” NeuroReport, vol. 12, no. 7, pp. 1453–1456, 2001. View at Google Scholar · View at Scopus
  16. C. F. Wu, Y. L. Liu, M. Song et al., “Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice,” Pharmacology Biochemistry and Behavior, vol. 76, no. 1, pp. 103–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Hao, J. Y. Yang, C. F. Wu, and M. F. Wu, “Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice,” Pharmacology Biochemistry and Behavior, vol. 86, no. 4, pp. 660–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Li, Y. Y. Guo, C. F. Wu, X. Li, and J. H. Wang, “Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats,” Journal of Pharmacy and Pharmacology, vol. 51, no. 4, pp. 435–440, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Mo, H. Zhang, L.-P. Yu, P.-H. Sun, G.-Z. Jin, and X. Zhen, “L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease,” Neurobiology of Aging, vol. 31, no. 6, pp. 926–936, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Capper-Loup, C. M. Frey, D. Rebell, and A. Kaelin-Lang, “Adaptive gene expression changes on the healthy side of parkinsonian rats,” Neuroscience, vol. 233, pp. 157–165, 2013. View at Google Scholar
  21. G. Khuwaja, M. M. Khan, T. Ishrat et al., “Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies,” Brain Research, vol. 1368, pp. 254–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Khan, A. Ahmad, T. Ishrat et al., “Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease,” Brain Research, vol. 1328, pp. 139–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. F. Wu, R. Bertorelli, M. Sacconi, G. Pepeu, and S. Consolo, “Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis,” Neurobiology of Aging, vol. 9, no. 4, pp. 357–361, 1988. View at Google Scholar · View at Scopus
  24. J. Y. Sun, J. Y. Yang, F. Wang et al., “Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats,” Addiction Biology, vol. 16, no. 4, pp. 540–550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-Y. Sun, J.-Y. Yang, F. Wang, Y. Hou, Y.-X. Dong, and C.-F. Wu, “GABAA receptors in VTA mediate the morphine-induced release of ascorbic acid in rat nucleus accumbens,” Brain Research, vol. 1368, pp. 52–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Liu, C. F. Wu, M. Huang, and K. Xiao, “Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats,” Brain Research, vol. 869, no. 1-2, pp. 31–38, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. D. Teixeira, C. M. Souza, A. P. Menezes et al., “Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats,” Pharmacology Biochemistry and Behavior, vol. 110C, pp. 1–7, 2013. View at Google Scholar
  28. D. Blum, S. Torch, N. Lambeng et al., “Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease,” Progress in Neurobiology, vol. 65, no. 2, pp. 135–172, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Decressac, B. Mattsson, and A. Björklund, “Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease,” Experimental Neurology, vol. 235, no. 1, pp. 306–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Schober, “Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP,” Cell and Tissue Research, vol. 318, no. 1, pp. 215–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Henderson, S. Watson, G. M. Halliday, T. Heinemann, and M. Gerlach, “Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat,” Behavioural Brain Research, vol. 139, no. 1-2, pp. 105–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sánchez-Iglesias, E. Méndez-Álvarez, J. Iglesias-González et al., “Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease,” Journal of Neurochemistry, vol. 109, no. 3, pp. 879–888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Obata, Y. Yamanaka, H. Kinemuchi, and L. Oreland, “Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP+) into the striatum is associated with hydroxyl free radical generation,” Brain Research, vol. 906, no. 1-2, pp. 170–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Sachs and G. Jonsson, “Mechanisms of action of 6-hydroxydopamine,” Biochemical Pharmacology, vol. 24, no. 1, pp. 1–8, 1975. View at Google Scholar · View at Scopus
  35. A. S. Perumal, V. B. Gopal, W. K. Tordzro, T. B. Cooper, and J. L. Cadet, “Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain,” Brain Research Bulletin, vol. 29, no. 5, pp. 699–701, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Kumar, A. K. Agarwal, and P. K. Seth, “Free radical-generated neurotoxicity of 6-hydroxydopamine,” Journal of Neurochemistry, vol. 64, no. 4, pp. 1703–1707, 1995. View at Google Scholar · View at Scopus
  37. R. Andrew, D. G. Watson, S. A. Best, J. M. Midgley, H. Wenlong, and R. K. H. Petty, “The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls,” Neurochemical Research, vol. 18, no. 11, pp. 1175–1177, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Blandini, M.-T. Armentero, and E. Martignoni, “The 6-hydroxydopamine model: news from the past,” Parkinsonism & Related Disorders, vol. 14, no. 2, pp. S124–S129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Rice, “Ascorbate regulation and its neuroprotective role in the brain,” Trends in Neurosciences, vol. 23, no. 5, pp. 209–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. G. T. Vatassery, “In vitro oxidation of vitamin E, vitamin C, thiols and cholesterol in rat brain mitochondria incubated with free radicals,” Neurochemistry International, vol. 26, no. 5, pp. 527–535, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. F. E. Harrison and J. M. May, “Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2,” Free Radical Biology and Medicine, vol. 46, no. 6, pp. 719–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. V. Avshalumov, D. G. MacGregor, L. M. Sehgal, and M. E. Rice, “The glial antioxidant network and neuronal ascorbate: protective yet permissive for H2O2 signaling,” Neuron Glia Biology, vol. 1, no. 4, pp. 365–376, 2004. View at Google Scholar
  43. W.-M. Lin, Y.-M. Zhang, R. Moldzio, and W.-D. Rausch, “Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture,” Journal of Neural Transmission, Supplementa, no. 72, pp. 105–112, 2007. View at Publisher · View at Google Scholar · View at Scopus